FDA Inspection 1192281 — Takeda Manufacturing Singapore Pte. Ltd.
The FDA completed an inspection of Takeda Manufacturing Singapore Pte. Ltd. on November 18, 2022 in Singapore. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 18, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Singapore (Singapore)